Evidence map›Paper›PMID 42653400›Full record

ArticleInternational journal of molecular sciences2026

Real-World Effectiveness and Safety of Allergen Immunotherapy with a Combination of Glutaraldehyde-Polymerized Allergen Extracts of

Francisco Javier Carballada González, Fernando García González, Belén Hinojosa Jara, Fernando Rodríguez Fernández, Miguel Añó García, Antonio Maraví San Martín, Luis Alfredo González Guzmán, Irene García Gutiérrez, Sofía Alonso Juaristi, María Jesús Giménez Revilla and 3 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Francisco Javier Carballada GonzálezLucus Augusti University Hospital, 27003 Lugo, Spain.
Fernando García GonzálezUniversity Hospital Basurto, 48013 Bilbao, Spain.
Belén Hinojosa JaraBelén Hinojosa Medical Clinic, 21001 Huelva, Spain.
Fernando Rodríguez FernándezUniversity Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Miguel Añó GarcíaAlergocantabria, 39002 Santander, Spain.
Antonio Maraví San MartínCentro Médico Sanitas Sevilla, 41010 Sevilla, Spain.
Luis Alfredo González GuzmánLucus Augusti University Hospital, 27003 Lugo, Spain.ORCID 0000-0002-7474-7305
Irene García GutiérrezUniversity Hospital Marqués de Valdecilla, 39008 Santander, Spain.ORCID 0000-0002-9176-1424
Sofía Alonso JuaristiUniversity Hospital Marqués de Valdecilla, 39008 Santander, Spain.
María Jesús Giménez RevillaUniversity Hospital Basurto, 48013 Bilbao, Spain.
Miguel CasanovasInmunotek S.L., Punto Mobi 5, Alcalá de Henares, 28805 Madrid, Spain.ORCID 0000-0003-2330-3963
Judith Díaz-GarcíaInmunotek S.L., Punto Mobi 5, Alcalá de Henares, 28805 Madrid, Spain.ORCID 0000-0001-7216-8281
Yara Ruiz GarcíaInmunotek S.L., Punto Mobi 5, Alcalá de Henares, 28805 Madrid, Spain.

Funding

Inmunotek (Spain)
6 · The paper itself

Abstract

Mite-induced allergic respiratory diseases are a major global health concern, and evidence on allergen immunotherapy (AIT) combining allergens from different mite families remains limited, particularly for

Indexed as

AllergensAntigens, DermatophagoidesAsthmaConjunctivitis, AllergicDesensitization, ImmunologicGlutaralMitesAdolescentAdultAnimalsChildDust Mite AllergyFemaleHumansMaleMiddle AgedAllergensAntigens, DermatophagoidesGlutaralallergen immunotherapyDermatophagoidesLepidoglyphus destructorreal-world evidence

Identifiers

PMID42653400
PMCPMC13513068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.